{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:12:44Z","timestamp":1774991564262,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd013433","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000}}],"reference-count":121,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013433.pub2","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T02:26:05Z","timestamp":1626834365000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Stem cell therapy for dilated cardiomyopathy"],"prefix":"10.1002","volume":"2021","author":[{"given":"Rienzi","family":"Diaz-Navarro","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine; Universidad de Valparaiso; Vina del Mar Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Urr\u00fatia","sequence":"additional","affiliation":[{"name":"Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau); CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP); Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John GF","family":"Cleland","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute; Imperial College London; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Poloni","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine; Universidad de Valparaiso; Vina del Mar Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Villagran","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine; Universidad de Valparaiso; Vina del Mar Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Acosta-Dighero","sequence":"additional","affiliation":[{"name":"Cochrane Chile Associate Centre; Universidad de Valpara\u00edso; Valpara\u00edso Chile"},{"name":"School of Physiotherapy, Faculty of Health Sciences; Universidad San Sebastian; Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrikant I","family":"Bangdiwala","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact; McMaster University; Hamilton Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Rada","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Evidence-Based Healthcare Program, Faculty of Medicine; Pontificia Universidad Cat\u00f3lica de Chile; Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Madrid","sequence":"additional","affiliation":[{"name":"Interdisciplinary Centre for Health Studies CIESAL, Universidad de Valpara\u00edso; Vi\u00f1a del Mar Chile"},{"name":"Cochrane Chile Associate Centre, Universidad de Valpara\u00edso; Valpara\u00edso Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD013433.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2217\/rme.11.29","article-title":"The Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy (REGENERATE-DCM) trial: study design","volume":"6","author":"Arnous","year":"2011","journal-title":"Regenerative Medicine"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0002|cit2","unstructured":"Randomised controlled trial to compare the effects of G-CSF(Granocyte\u2122) and autologous bone marrow progenitor cells on quality of life and left ventricular function In patients with idiopathic dilated cardiomyopathy - REGENERATE-DCM ddrare.nibiohn.go.jp\/cgi-bin\/disease_who_e.cgi?id=57"},{"issue":"44","key":"10.1002\/14651858.CD013433.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1093\/eurheartj\/ehv390","article-title":"Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial","volume":"36","author":"Hamshere","year":"2015","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0004|cit4","unstructured":"Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy (REGEN-DCM) clinicaltrials.gov\/ct2\/show\/NCT01302171"},{"issue":"5","key":"10.1002\/14651858.CD013433.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM trial","volume":"69","author":"Hare","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD013433.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s12265-014-9594-0","article-title":"Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I\/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathy","volume":"7","author":"Mushtaq","year":"2014","journal-title":"Journal of Cardiovascular Translational Research"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/sctm.16-0328","article-title":"Effects of transendocardial stem cell injection on ventricular proarrhythmia in patients with ischemic cardiomyopathy: results from the POSEIDON and TAC-HFT Trials","volume":"6","author":"Ramireddy","year":"2017","journal-title":"Stem Cells Translational Medicine"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.healun.2011.01.225","article-title":"IMPACT-DCM: a randomized, controlled, multi-center phase II trial utilizing expanded autologous bone marrow as sole therapy for dilated cardiomyopathy study update","volume":"30","author":"Bruckner","year":"2011","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.healun.2012.01.191","article-title":"Safety and efficacy of ixmyelocel-t, an expanded patient-specific mixed cell product, in dilated cardiomyopathy (IMPACT-DCM)","volume":"31","author":"Bunge","year":"2012","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD013433.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/CIRCRESAHA.115.304554","article-title":"Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy","volume":"115","author":"Henry","year":"2014","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cardfail.2011.06.196","article-title":"Safety and efficacy of ixmyelocel-T, an expanded patient-specific mixed cell product, in dilated cardiomyopathy (IMPACT-DCM)","volume":"17","author":"Patel","year":"2011","journal-title":"Journal of Cardiac Failure"},{"issue":"42","key":"10.1002\/14651858.CD013433.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/eurheartj\/ehv477","article-title":"Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study)","volume":"36","author":"Martino","year":"2015","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-6215-8-2","article-title":"Multicenter randomized trial of cell therapy in cardiopathies MiHeart study","volume":"8","author":"Tura","year":"2007","journal-title":"Trials"},{"issue":"3","key":"10.1002\/14651858.CD013433.pub2-BIB0014|cit14","first-page":"437","article-title":"Direct intramyocardial transthoracic transplantation of bone marrow mononuclear cells for non-ischemic dilated cardiomyopathy: INTRACELL, a prospective randomized controlled trial","volume":"29","author":"Sant'Anna","year":"2014","journal-title":"Revista Brasileira de Cirurgia Cardiovascular"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0015|cit15","first-page":"501","article-title":"A randomised trial of Autologous Bone marrow Cells in Dilated cardiomyopathy (ABCD)","volume":"30","author":"Seth","year":"2009","journal-title":"European Heart Journal"},{"issue":"15","key":"10.1002\/14651858.CD013433.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2009.11.070","article-title":"The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial: a long-term follow-up study","volume":"55","author":"Seth","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD013433.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2006.07.057","article-title":"Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone marrow Cells in Dilated cardiomyopathy) trial","volume":"48","author":"Seth","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013433.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cardfail.2010.11.007","article-title":"Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy","volume":"17","author":"Vrtovec","year":"2011","journal-title":"Journal of Cardiac Failure"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/circresaha.112.276519","article-title":"Effects of intracoronary CD34+ stem cell transplantation in non-ischemic dilated cardiomyopathy patients: 5-year follow up","volume":"112","author":"Vrtovec","year":"2012","journal-title":"Circulation Research"},{"issue":"1","key":"10.1002\/14651858.CD013433.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","article-title":"Effects of intracoronary CD34+stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up","volume":"112","author":"Vrtovec","year":"2013","journal-title":"Circulation Research"},{"issue":"Suppl II","key":"10.1002\/14651858.CD013433.pub2-BIB0021|cit21","first-page":"373","article-title":"Long-term effects of stem cell transplantation in heart failure","volume":"81","author":"Vrtovec","year":"2012","journal-title":"Zdravniski Vestnik"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0022|cit22","first-page":"21","article-title":"Comparison of clinical effects of transendocardial vs. intracoronary stem cell transplantation in dilated cardiomyopathy","volume":"126","author":"Vrtovec","year":"2012","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD013433.pub2-BIB0023|cit23","first-page":"S42","article-title":"Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy","volume":"128","author":"Vrtovec","year":"2013","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/sctm.17-0197","article-title":"CD34(+) cell transplantation improves right ventricular function in patients with nonischemic dilated cardiomyopathy","volume":"7","author":"Frljak","year":"2018","journal-title":"Stem Cells Translational Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013433.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/CIRCRESAHA.117.312170","article-title":"Effects of repetitive transendocardial CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy","volume":"123","author":"Vrtovec","year":"2018","journal-title":"Circulation Research"},{"issue":"2","key":"10.1002\/14651858.CD013433.pub2-BIB0026|cit26","first-page":"107","article-title":"A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy","volume":"34","author":"Wang","year":"2006","journal-title":"Chung Hua Hsin Hsueh Kuan Ping Tsa Chih"},{"issue":"1","key":"10.1002\/14651858.CD013433.pub2-BIB0027|cit27","first-page":"121","article-title":"Autologous peripheral blood stem cells transplantation for the treatment of dilated cardiomyopathy: a 24-month follow-up in 38 cases","volume":"14","author":"Wu","year":"2010","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"issue":"2","key":"10.1002\/14651858.CD013433.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1536\/ihj.16-328","article-title":"A randomized comparative study on the efficacy of intracoronary infusion of autologous bone marrow mononuclear cells and mesenchymal stem cells in patients with dilated cardiomyopathy","volume":"58","author":"Xiao","year":"2017","journal-title":"International Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD013433.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4067\/S0034-98872015000400001","article-title":"Long-term results of intracoronary transplantation of autologous bone marrow cells in dilated cardiomyopathy","volume":"143","author":"Bartolucci","year":"2015","journal-title":"Revista M\u00e9dica de Chile"},{"issue":"10","key":"10.1002\/14651858.CD013433.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","article-title":"Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1\/2 randomized controlled trial (RIMECARD trial [Randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy])","volume":"121","author":"Bartolucci","year":"2017","journal-title":"Circulation Research"},{"issue":"1","key":"10.1002\/14651858.CD013433.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2008.06.002","article-title":"Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure","volume":"138","author":"Bocchi","year":"2010","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD013433.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCRESAHA.116.309717","article-title":"Intravenous allogeneic mesenchymal stem cells for nonischemic cardiomyopathy: safety and efficacy results of a phase II - a randomized trial","volume":"120","author":"Butler","year":"2017","journal-title":"Circulation Research"},{"issue":"12","key":"10.1002\/14651858.CD013433.pub2-BIB0033|cit33","first-page":"1087","article-title":"Effects of intracoronary autologous bone marrow mononuclear cells transplantation in patients with dilated cardiomyopathy","volume":"36","author":"Chen","year":"2008","journal-title":"Zhonghua Xin Xue GuanBing Za Zhi"},{"issue":"5","key":"10.1002\/14651858.CD013433.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCHEARTFAILURE.109.855023","article-title":"A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy","volume":"2","author":"Fischer-Rasokat","year":"2009","journal-title":"Circulation. Heart Failure"},{"issue":"2","key":"10.1002\/14651858.CD013433.pub2-BIB0035|cit35","first-page":"111","article-title":"Transplantation of autologous bone marrow mononuclear cells on patients with idiopathic dilated cardiomyopathy: early results on effect and security","volume":"34","author":"Huang","year":"2006","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0036|cit36","first-page":"568","article-title":"Bone-marrow progenitor stem cells for the treatment of patients with congestive heart failure of different etiology in a placebo controlled clinical trial","volume":"12","author":"Kakuchaya","year":"2011","journal-title":"Interactive Cardiovascular and Thoracic Surgery"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0037|cit37","first-page":"290","article-title":"Accurate design of randomized placebo-controlled clinical trials for assessment of stem cell effects on cardiac regeneration","volume":"32","author":"Kakuchaya","year":"2011","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD013433.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"e003918","DOI":"10.1161\/JAHA.116.003918","article-title":"Phase I clinical trial of autologous stem cell-sheet transplantation therapy for treating cardiomyopathy","volume":"6","author":"Miyagawa","year":"2017","journal-title":"Journal American Heart Association"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0039|cit39","unstructured":"Intracoronary transplantation of bone marrow derived mononuclear cells in pediatric cardiomyopathy clinicaltrials.gov\/ct2\/show\/NCT02256501"},{"issue":"6","key":"10.1002\/14651858.CD013433.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCRESAHA.115.306332","article-title":"A phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure","volume":"117","author":"Perin","year":"2015","journal-title":"Circulation Research"},{"issue":"5","key":"10.1002\/14651858.CD013433.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ebiom.2015.03.020","article-title":"Allogeneic mesenchymal stem cells restore endothelial function in heart failure by stimulating endothelial progenitor cells","volume":"2","author":"Premer","year":"2015","journal-title":"EBioMedicine"},{"issue":"14","key":"10.1002\/14651858.CD013433.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"e008460","DOI":"10.1161\/JAHA.117.008460","article-title":"Comparison of mesenchymal stem cell efficacy in ischemic versus nonischemic dilated cardiomyopathy","volume":"7","author":"Tompkins","year":"2018","journal-title":"Journal of the American Heart Association"},{"issue":"7","key":"10.1002\/14651858.CD013433.pub2-BIB0043|cit43","first-page":"575","article-title":"Comparative study on the efficacy of intracoronary infusion with various types of autologous bone marrow stem cells for patients with dilated cardiomyopathy","volume":"40","author":"Xiao","year":"2012","journal-title":"Zhonghua Xin XueGuan Bing Za Zhi"},{"issue":"27","key":"10.1002\/14651858.CD013433.pub2-BIB0044|cit44","first-page":"5081","article-title":"Autologous bone marrow mesenchymal stem cells for myocardial renewal and repair","volume":"16","author":"Xiao","year":"2012","journal-title":"Chinese Journal of Tissue Engineering Research"},{"issue":"12","key":"10.1002\/14651858.CD013433.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/jama.2019.2341","article-title":"Intramyocardial injection of mesenchymal precursor cells and successful temporary weaning from left ventricular assist device support in patients with advanced heart failure: a randomized clinical trial","volume":"321","author":"Yau","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD013433.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cardfail.2016.08.002","article-title":"Electroanatomic properties of the myocardium predict response to CD34+ cell therapy in patients with ischemic and nonischemic heart failure","volume":"23","author":"Zemljic","year":"2017","journal-title":"Journal of Cardiac Failure"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0047|cit47","unstructured":"Mesenchymal stem cells for idiopathic dilated cardiomyopathy clinicaltrials.gov\/ct2\/show\/NCT01957826"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0048|cit48","unstructured":"Infusion intracoronary of mononuclear autologous adult no expanded stem cells of bone marrow on functional recovery in patients with idiopathic dilated cardiomyopathy and heart failure clinicaltrials.gov\/ct2\/show\/NCT02033278"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0049|cit49","unstructured":"Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC) clinicaltrials.gov\/ct2\/show\/NCT02293603"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0050|cit50","unstructured":"Stem cell therapy in non-ischemic non-treatable dilated cardiomyopathies II: a pilot study clinicaltrials.gov\/ct2\/show\/NCT03797092"},{"issue":"24","key":"10.1002\/14651858.CD013433.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1161\/01.CIR.0000043246.74879.CD","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)","volume":"106","author":"Assmus","year":"2002","journal-title":"Circulation"},{"issue":"21","key":"10.1002\/14651858.CD013433.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/eurheartj\/ehv559","article-title":"Improved outcome with repeated intracoronary injection of bone marrow-derived cells within a registry: rationale for the randomized outcome trial REPEAT","volume":"37","author":"Assmus","year":"2016","journal-title":"European Heart Journal"},{"issue":"23","key":"10.1002\/14651858.CD013433.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","article-title":"Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics","volume":"61","author":"Bartunek","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD013433.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ejhf.434","article-title":"Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design","volume":"18","author":"Bartunek","year":"2016","journal-title":"European Journal of Heart Failure"},{"issue":"9","key":"10.1002\/14651858.CD013433.pub2-BIB0055|cit55","first-page":"648","article-title":"Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial","volume":"38","author":"Bartunek","year":"2017","journal-title":"European Heart Journal"},{"issue":"10","key":"10.1002\/14651858.CD013433.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/CIRCRESAHA.118.312753","article-title":"Clinical experience with regenerative therapy in heart failure: advancing care with cardiopoietic stem cell interventions","volume":"122","author":"Bartunek","year":"2018","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrcardio.2014.9","article-title":"Cell therapy for cardiac repair-lessons from clinical trials","volume":"11","author":"Behfar","year":"2014","journal-title":"Nature Reviews. Cardiology"},{"issue":"21","key":"10.1002\/14651858.CD013433.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/eurheartj\/ehv596","article-title":"Repetition rescues regenerative reserve","volume":"37","author":"Behfar","year":"2016","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD013433.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(01)00409-3","article-title":"The evolving concept of a stem cell: entity or function?","volume":"105","author":"Blau","year":"2001","journal-title":"Cell"},{"issue":"18","key":"10.1002\/14651858.CD013433.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMra1716145","article-title":"Stem cells in the treatment of disease","volume":"380","author":"Blau","year":"2019","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD013433.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41587-019-0042-1","article-title":"Regenerating the field of cardiovascular cell therapy","volume":"37","author":"Chien","year":"2019","journal-title":"Nature Biotechnology"},{"issue":"3","key":"10.1002\/14651858.CD013433.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/eurheartj\/ehv493","article-title":"A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial","volume":"37","author":"Choudry","year":"2016","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0064|cit64","volume-title":"Statistical Power Analysis in the Behavioural Sciences","author":"Cohen","year":"1988"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0065|cit65","unstructured":"Veritas Health Innovation Covidence"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJM199412083312307","article-title":"Idiopathic dilated cardiomyopathy","volume":"331","author":"Dec","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0067|cit67","unstructured":"Deeks JJ Higgins JP Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from training.cochrane.org\/handbook\/archive\/v5.2"},{"issue":"3","key":"10.1002\/14651858.CD013433.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD013433.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/hrt.58.4.393","article-title":"Prediction of outcome in dilated cardiomyopathy","volume":"58","author":"D\u00edaz","year":"1987","journal-title":"British Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD013433.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCHEARTFAILURE.111.966366","article-title":"Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction","volume":"5","author":"Dunlay","year":"2012","journal-title":"Circulation Heart Failure"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD013433.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/01.RES.0000185811.71306.8b","article-title":"Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study","volume":"97","author":"Erbs","year":"2005","journal-title":"Circulation Research"},{"issue":"9","key":"10.1002\/14651858.CD013433.pub2-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006536.pub4","article-title":"Stem cell treatment for acute myocardial infarction","author":"Fisher","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD013433.pub2-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007888.pub3","article-title":"Stem cell therapy for chronic ischaemic heart disease and congestive heart failure","author":"Fisher","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013433.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.344","article-title":"Cell therapy for heart disease: trial sequential analyses of two Cochrane reviews","volume":"100","author":"Fisher","year":"2016","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/sctm.17-0197","article-title":"CD34+ cell transplantation improves right ventricular function in patients with nonischemic dilated cardiomyopathy","volume":"7","author":"Frljak","year":"2018","journal-title":"Stem Cells Translational Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013433.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9149(81)90534-8","article-title":"The natural history of idiopathic dilated cardiomyopathy","volume":"47","author":"Fuster","year":"1981","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0078|cit78","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nm1199","article-title":"G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes","volume":"11","author":"Harada","year":"2005","journal-title":"Nature Medicine"},{"issue":"20","key":"10.1002\/14651858.CD013433.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"issue":"24","key":"10.1002\/14651858.CD013433.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","article-title":"A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction","volume":"54","author":"Hare","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM trial","volume":"69","author":"Hare","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD013433.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0084|cit84","unstructured":"Higgins JP Deeks JJ Altman DG Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from \u00a0training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0085|cit85","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from training.cochrane.org\/handbook\/archive\/v5.2"},{"issue":"9716","key":"10.1002\/14651858.CD013433.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(09)62023-7","article-title":"Dilated cardiomyopathy","volume":"375","author":"Jefferies","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD013433.pub2-BIB0087|cit87","first-page":"1463","article-title":"Effects of stem cell therapy on dilated cardiomyopathy","volume":"35","author":"Jiao","year":"2014","journal-title":"Saudi Medical Journal"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0088|cit88","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"7","key":"10.1002\/14651858.CD013433.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013433.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13287-016-0441-x","article-title":"A systematic review of randomised controlled trials examining the therapeutic effects of adult bone marrow-derived stem cells for non-ischaemic dilated cardiomyopathy","volume":"7","author":"Lu","year":"2016","journal-title":"Stem Cell Research & Therapy"},{"issue":"11","key":"10.1002\/14651858.CD013433.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.cjca.2014.03.026","article-title":"Stem cell therapy for the treatment of nonischemic cardiomyopathy: a systematic review of the literature and meta-analysis of randomized controlled trials","volume":"30","author":"Marquis-Gravel","year":"2014","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCRESAHA.117.309711","article-title":"Classification, epidemiology, and global burden of cardiomyopathies","volume":"121","author":"McKenna","year":"2017","journal-title":"Circulation Research"},{"issue":"9252","key":"10.1002\/14651858.CD013433.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(00)03617-5","article-title":"Myoblast transplantation for heart failure","volume":"357","author":"Menasch\u00e9","year":"2001","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD013433.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","article-title":"Cell therapy trials for heart regeneration-lessons learned and future directions","volume":"15","author":"Menasch\u00e9","year":"2018","journal-title":"Nature Reviews. Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD013433.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ejhf.16","article-title":"Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years","volume":"16","author":"Merlo","year":"2014","journal-title":"European Journal of Heart Failure"},{"issue":"1","key":"10.1002\/14651858.CD013433.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"e001504","DOI":"10.1161\/JAHA.114.001504","article-title":"Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long-term follow-up: does real healing exist?","volume":"4","author":"Merlo","year":"2015","journal-title":"Journal of the American Heart Association"},{"issue":"2","key":"10.1002\/14651858.CD013433.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/14779072.2016.1125292","article-title":"Clinical management of dilated cardiomyopathy: current knowledge and future perspectives","volume":"14","author":"Merlo","year":"2016","journal-title":"Expert Review of Cardiovascular Therapy"},{"issue":"9","key":"10.1002\/14651858.CD013433.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.5966\/sctm.2015-0070","article-title":"REVIVE trial: retrograde delivery of autologous bone marrow in patients with heart failure","volume":"4","author":"Patel","year":"2015","journal-title":"Stem Cells Translational Medicine"},{"issue":"23","key":"10.1002\/14651858.CD013433.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"6487812","DOI":"10.1155\/2018\/6487812","article-title":"Stem cell therapy in patients with chronic nonischemic heart failure","volume":"2018","author":"Poglajen","year":"2018","journal-title":"Stem Cells International"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12265-009-9138-1","article-title":"Intramyocardial navigation and mapping for stem cell delivery","volume":"3","author":"Psaltis","year":"2010","journal-title":"Journal of Cardiovascular Translational Research"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0103|cit103","unstructured":"R Foundation for Statistical Computing R: a language and environment for statistical computing 2017"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0104|cit104","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"1","key":"10.1002\/14651858.CD013433.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12967-019-1966-4","article-title":"Efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy: a systematic appraisal and meta-analysis","volume":"17","author":"Rong","year":"2019","journal-title":"Journal of Translational Medicine"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0107|cit107","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from training.cochrane.org\/handbook\/archive\/v5.2"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(03)12110-1","article-title":"Autologous bone-marrow stem-cell transplantation for myocardial regeneration","volume":"361","author":"Stamm","year":"2003","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD013433.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.healun.2011.08.003","article-title":"The registry of the International Society of Heart and Lung Transplantation: twenty-eight adult heart transplantation report","volume":"30","author":"Stehlik","year":"2011","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/01.CIR.0000034046.87607.1C","article-title":"Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans","volume":"106","author":"Strauer","year":"2002","journal-title":"Circulation"},{"issue":"14","key":"10.1002\/14651858.CD013433.pub2-BIB0111|cit111","first-page":"1089","article-title":"CardioPulse: regenerative medicine in the practice of cardiology","volume":"37","author":"Terzic","year":"2016","journal-title":"European Heart Journal"},{"issue":"11","key":"10.1002\/14651858.CD013433.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/CIRCRESAHA.117.312074","article-title":"Posology for regenerative therapy","volume":"121","author":"Terzic","year":"2017","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","article-title":"Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up","volume":"112","author":"Vrtovec","year":"2013","journal-title":"Circulation Research"},{"issue":"122","key":"10.1002\/14651858.CD013433.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCRESAHA.117.312385","article-title":"Cell therapy for nonischemic cardiomyopathy: current status and future perspectives","volume":"5","author":"Vrtovec","year":"2018","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD013433.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/CIRCRESAHA.117.312170","article-title":"Effects of repetitive transendocardial CD34(+) cell transplantation in patients with nonischemic dilated cardiomyopathy","volume":"123","author":"Vrtovec","year":"2018","journal-title":"Circulation Research"},{"issue":"10092","key":"10.1002\/14651858.CD013433.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD013433.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"e12894","DOI":"10.1111\/eci.12894","article-title":"Bone marrow-derived mononuclear cell therapy for nonischaemic dilated cardiomyopathy. A meta-analysis","volume":"48","author":"Wen","year":"2018","journal-title":"European Journal of Clinical Investigation"},{"issue":"6","key":"10.1002\/14651858.CD013433.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/hrt.44.6.672","article-title":"Report of the WHO\/ISFC task force on the definition and classification of cardiomyopathies","volume":"44","author":"World Health Organization\/International Society and Federation of Cardiology","year":"1980","journal-title":"British Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD013433.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/sctm.19-0149","article-title":"Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy","volume":"9","author":"Yamada","year":"2020","journal-title":"Stem Cells Translational Medicine"},{"issue":"16","key":"10.1002\/14651858.CD013433.pub2-BIB0120|cit120","first-page":"e240","article-title":"ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"9","key":"10.1002\/14651858.CD013433.pub2-BIB0121|cit121","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013433","article-title":"Stem cell therapy for dilated cardiomyopathy","author":"Diaz-Navarro","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T16:30:10Z","timestamp":1673368210000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013433.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":121,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013433.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]}}}